{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:00:14Z","timestamp":1769752814848,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11096-020-01113-1","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T21:17:40Z","timestamp":1597007860000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of pharmaceutical care on the efficacy and safety of transdermal glucosamine sulfate and capsaicin for joint pain"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-8804","authenticated-orcid":false,"given":"Ala Y.","family":"Issa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam A.","family":"ALSalamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wedad B.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rand M.","family":"Haddaden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen M.","family":"Aleidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"key":"1113_CR1","first-page":"173","volume":"8","author":"W Wolfram","year":"2016","unstructured":"Wolfram W, Christian H, Christopher C, Malte S, Michael H. Effect of glucosamine sulfate on osteoarthritis in the cruciate-deficient canine model of osteoarthritis. Cartilage. 2016;8:173\u20139.","journal-title":"Cartilage"},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar4173","volume":"15","author":"LS Simon","year":"2013","unstructured":"Simon LS. Nonsteroidal anti-inflammatory drugs and their risk: a story still in development. Arthritis Res Ther. 2013;15:S1.","journal-title":"Arthritis Res Ther"},{"key":"1113_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14740\/gr658w","volume":"8","author":"S Chatterjee","year":"2015","unstructured":"Chatterjee S, Dureja GP, Kadhe G, Mane A, Phansalkar AA, Sawant S, et al. Cross-sectional study for prevalence of non-steroidal anti-inflammatory drug-induced gastrointestinal, cardiac and renal complications in india: interim report. Gastroenterol Res. 2015;8:216\u201321.","journal-title":"Gastroenterol Res"},{"key":"1113_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2474-6-20","volume":"6","author":"RM Rozendaal","year":"2005","unstructured":"Rozendaal RM, Koes BW, Weinans H, Uitterlinden EJ, van Osch GJ, Ginai AZ, et al. The effect of glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial [ISRCTN54513166]. BMC Musculoskelet Disord. 2005;6:20.","journal-title":"BMC Musculoskelet Disord"},{"key":"1113_CR5","doi-asserted-by":"crossref","unstructured":"Towheed T ML, Anastassiades TP, Shea B, Houpt JB, Welch V, Hochberg MC, Wells GA. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews. The Cochrane database of systematic reviews 2005.","DOI":"10.1002\/14651858.CD002946.pub2"},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5312\/wjo.v8.i1.1","volume":"8","author":"HS Vasiliadis","year":"2017","unstructured":"Vasiliadis HS, Tsikopoulos K. Glucosamine and chondroitin for the treatment of osteoarthritis. World J Orthop. 2017;8:1\u201311.","journal-title":"World J Orthop"},{"key":"1113_CR7","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00296-012-2416-2","volume":"32","author":"JY Reginster","year":"2012","unstructured":"Reginster JY, Neuprez A, Lecart MP, Sarlet N, Bruyere O. Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int. 2012;32:2959\u201367.","journal-title":"Rheumatol Int"},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/joca.1999.0299","volume":"8","author":"JI Fenton","year":"2000","unstructured":"Fenton JI, Chlebek-Brown KA, Peters TL, Caron JP, Orth MW. Glucosamine HCl reduces equine articular cartilage degradation in explant culture. Osteoarthr Cartil. 2000;8:258\u201365.","journal-title":"Osteoarthr Cartil"},{"key":"1113_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2011.01.007","volume":"405","author":"K Imagawa","year":"2011","unstructured":"Imagawa K, de Andres MC, Hashimoto K, Pitt D, Itoi E, Goldring MB, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes\u2013implications for osteoarthritis. Biochem Biophys Res Commun. 2011;405:362\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1113_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S1063-4584(03)00028-1","volume":"11","author":"R Largo","year":"2003","unstructured":"Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, et al. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthr Cartil. 2003;11:290\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"1113_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1248\/bpb.b16-00877","volume":"40","author":"T Takeuchi","year":"2017","unstructured":"Takeuchi T, Sugimoto A, Imazato N, Tamura M, Nakatani S, Kobata K, et al. Glucosamine Suppresses Osteoclast Differentiation through the Modulation of Glycosylation Including O-GlcNAcylation. Biol Pharm Bull. 2017;40:352\u20136.","journal-title":"Biol Pharm Bull"},{"key":"1113_CR12","doi-asserted-by":"publisher","first-page":"c4675","DOI":"10.1136\/bmj.c4675","volume":"341","author":"S Wandel","year":"2010","unstructured":"Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ Clin Res Ed. 2010;341:c4675.","journal-title":"BMJ Clin Res Ed"},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"16827","DOI":"10.1038\/srep16827","volume":"5","author":"C Zeng","year":"2015","unstructured":"Zeng C, Wei J, Li H, Wang YL, Xie DX, Yang T, et al. Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. Sci Rep. 2015;5:16827.","journal-title":"Sci Rep"},{"key":"1113_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00296-006-0197-1","volume":"27","author":"H Nakamura","year":"2007","unstructured":"Nakamura H, Masuko K, Yudoh K, Kato T, Kamada T, Kawahara T. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol Int. 2007;27:213\u20138.","journal-title":"Rheumatol Int"},{"issue":"Suppl","key":"1113_CR15","first-page":"3","volume":"3","author":"NGH Mlym","year":"2011","unstructured":"Mlym NGH, Obaje J. Transdermal glucosamine formulation improves osteoarthritic symptoms in an open clinical survey. Int J Pharm Pharm Sci. 2011;3(Suppl):3.","journal-title":"Int J Pharm Pharm Sci"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01113-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T23:34:31Z","timestamp":1628465671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01113-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01113-1","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,9]]},"assertion":[{"value":"30 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors stated that there was no conflict of interest regarding the study design and publication of the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}